Palbociclib

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2609 publications

Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summary.

Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summary.

Journal: Future oncology (London, England)

Published: June 22, 2026

Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary.

Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary.

Journal: Future oncology (London, England)

Published: June 22, 2026

Mechanistic PBPK Modeling of pH-Modifying Excipient Effects to Guide Formulation Design for Mitigating pH-Mediated DDIs.

Mechanistic PBPK Modeling of pH-Modifying Excipient Effects to Guide Formulation Design for Mitigating pH-Mediated DDIs.

Journal: Molecular pharmaceutics

Published: June 16, 2026

Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 04, 2026

Wip1 Inhibition Enhances the Therapeutic Efficacy of Palbociclib in Luminal A Breast Cancer by Modulating Cell Cycle Progression and Apoptosis.

Wip1 Inhibition Enhances the Therapeutic Efficacy of Palbociclib in Luminal A Breast Cancer by Modulating Cell Cycle Progression and Apoptosis.

Journal: Folia biologica

Published: May 20, 2026

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals.

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals.

Journal: Cureus

Published: May 17, 2026

Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study.

Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 14, 2026

An Extreme Clinical Diagnosis: Primary Metastatic Breast Cancer with Complete Bilateral Breast Contour Elimination and Ulceration.

An Extreme Clinical Diagnosis: Primary Metastatic Breast Cancer with Complete Bilateral Breast Contour Elimination and Ulceration.

Journal: Diagnostics (Basel, Switzerland)

Published: May 13, 2026

Circular-by-Design Zwitterionic Polyglycerol-Polyoxazoline-Lysine Pseudodendrimers as Multifunctional Antibacterial and Anticancer Drug Delivery Platforms.

Circular-by-Design Zwitterionic Polyglycerol-Polyoxazoline-Lysine Pseudodendrimers as Multifunctional Antibacterial and Anticancer Drug Delivery Platforms.

Journal: Biomacromolecules

Published: May 07, 2026

Palbociclib for HR-Positive, HER2-Positive Breast Cancer.

Palbociclib for HR-Positive, HER2-Positive Breast Cancer.

Journal: The New England journal of medicine

Published: April 29, 2026

Palbociclib for HR-Positive, HER2-Positive Breast Cancer.

Palbociclib for HR-Positive, HER2-Positive Breast Cancer.

Journal: The New England journal of medicine

Published: April 29, 2026

Palbociclib for HR-Positive, HER2-Positive Breast Cancer. Reply.

Palbociclib for HR-Positive, HER2-Positive Breast Cancer. Reply.

Journal: The New England journal of medicine

Published: April 29, 2026

Showing 1-12 of 2,609

Last Updated: 06/30/2026